91Ë¿¹ÏÊÓƵ

New Therapeutic Trial Designs in Personalized Medicine: Molecular Oncology

Ìý

The Molecular Oncology research team includes internationally recognized researchers with expertise in regulation of oncogene expression, signal transduction, evaluation of normal and malignant development in animal models, structural biology and bioinformatics. Their focus is on the molecular mechanisms underlying oncogenic development.

Theme leaders:

Dr. Wilson H. Miller Jr, Lady Davis Institute for Medical Research, 91Ë¿¹ÏÊÓƵ

Dr. Sarit Assouline, Lady Davis Institute for Medical Research, 91Ë¿¹ÏÊÓƵ

Members:

Dr. Mark Basik, Lady Davis Institute for Medical Research, 91Ë¿¹ÏÊÓƵ

Dr. Volker Blank, Lady Davis Institute for Medical Research, 91Ë¿¹ÏÊÓƵ

Dr. Sonia del Rincon, Lady Davis Institute for Medical Research, 91Ë¿¹ÏÊÓƵ

Dr. Antonis Koromilas, Lady Davis Institute for Medical Research, 91Ë¿¹ÏÊÓƵ

Dr. Alexandre Orthwein, Lady Davis Institute for Medical Research, 91Ë¿¹ÏÊÓƵ

Dr. Stéphane Richard, Lady Davis Institute for Medical Research, 91Ë¿¹ÏÊÓƵ

Dr. Josie Ursini-Siegel, Lady Davis Institute for Medical Research, 91Ë¿¹ÏÊÓƵ

Dr. Alan Spatz, Lady Davis Institute for Medical Research, 91Ë¿¹ÏÊÓƵ

Back to top